Ketosis Suppression and Ageing (KetoSAge) : The Effects of Suppressing Ketosis in Long Term Keto-Adapted Non-Athletic Females
Most studies on ketosis have focused on short-term effects, male athletes, or weight loss. Hereby, we studied the effects of short-term ketosis suppression in healthy women on long-standing ketosis. Ten lean (BMI 20.5 ± 1.4), metabolically healthy, pre-menopausal women (age 32.3 ± 8.9) maintaining nutritional ketosis (NK) for > 1 year (3.9 years ± 2.3) underwent three 21-day phases: nutritional ketosis (NK; P1), suppressed ketosis (SuK; P2), and returned to NK (P3). Adherence to each phase was confirmed with daily capillary D-beta-hydroxybutyrate (BHB) tests (P1 = 1.9 ± 0.7; P2 = 0.1 ± 0.1; and P3 = 1.9 ± 0.6 pmol/L). Ageing biomarkers and anthropometrics were evaluated at the end of each phase. Ketosis suppression significantly increased: insulin, 1.78-fold from 33.60 (± 8.63) to 59.80 (± 14.69) pmol/L (p = 0.0002); IGF1, 1.83-fold from 149.30 (± 32.96) to 273.40 (± 85.66) µg/L (p = 0.0045); glucose, 1.17-fold from 78.6 (± 9.5) to 92.2 (± 10.6) mg/dL (p = 0.0088); respiratory quotient (RQ), 1.09-fold 0.66 (± 0.05) to 0.72 (± 0.06; p = 0.0427); and PAI-1, 13.34 (± 6.85) to 16.69 (± 6.26) ng/mL (p = 0.0428). VEGF, EGF, and monocyte chemotactic protein also significantly increased, indicating a pro-inflammatory shift. Sustained ketosis showed no adverse health effects, and may mitigate hyperinsulinemia without impairing metabolic flexibility in metabolically healthy women.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
International journal of molecular sciences - 24(2023), 21 vom: 26. Okt. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cooper, Isabella D [VerfasserIn] |
---|
Links: |
---|
Themen: |
3-Hydroxybutyric Acid |
---|
Anmerkungen: |
Date Completed 15.11.2023 Date Revised 17.11.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/ijms242115621 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36450241X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM36450241X | ||
003 | DE-627 | ||
005 | 20231226095551.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/ijms242115621 |2 doi | |
028 | 5 | 2 | |a pubmed24n1214.xml |
035 | |a (DE-627)NLM36450241X | ||
035 | |a (NLM)37958602 | ||
035 | |a (PII)15621 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cooper, Isabella D |e verfasserin |4 aut | |
245 | 1 | 0 | |a Ketosis Suppression and Ageing (KetoSAge) |b The Effects of Suppressing Ketosis in Long Term Keto-Adapted Non-Athletic Females |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.11.2023 | ||
500 | |a Date Revised 17.11.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Most studies on ketosis have focused on short-term effects, male athletes, or weight loss. Hereby, we studied the effects of short-term ketosis suppression in healthy women on long-standing ketosis. Ten lean (BMI 20.5 ± 1.4), metabolically healthy, pre-menopausal women (age 32.3 ± 8.9) maintaining nutritional ketosis (NK) for > 1 year (3.9 years ± 2.3) underwent three 21-day phases: nutritional ketosis (NK; P1), suppressed ketosis (SuK; P2), and returned to NK (P3). Adherence to each phase was confirmed with daily capillary D-beta-hydroxybutyrate (BHB) tests (P1 = 1.9 ± 0.7; P2 = 0.1 ± 0.1; and P3 = 1.9 ± 0.6 pmol/L). Ageing biomarkers and anthropometrics were evaluated at the end of each phase. Ketosis suppression significantly increased: insulin, 1.78-fold from 33.60 (± 8.63) to 59.80 (± 14.69) pmol/L (p = 0.0002); IGF1, 1.83-fold from 149.30 (± 32.96) to 273.40 (± 85.66) µg/L (p = 0.0045); glucose, 1.17-fold from 78.6 (± 9.5) to 92.2 (± 10.6) mg/dL (p = 0.0088); respiratory quotient (RQ), 1.09-fold 0.66 (± 0.05) to 0.72 (± 0.06; p = 0.0427); and PAI-1, 13.34 (± 6.85) to 16.69 (± 6.26) ng/mL (p = 0.0428). VEGF, EGF, and monocyte chemotactic protein also significantly increased, indicating a pro-inflammatory shift. Sustained ketosis showed no adverse health effects, and may mitigate hyperinsulinemia without impairing metabolic flexibility in metabolically healthy women | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a ageing | |
650 | 4 | |a beta-hydroxybutyrate | |
650 | 4 | |a cancer | |
650 | 4 | |a hyperinsulinaemia | |
650 | 4 | |a insulin resistance | |
650 | 4 | |a ketosis | |
650 | 4 | |a type 2 diabetes mellitus | |
650 | 7 | |a Insulin |2 NLM | |
650 | 7 | |a 3-Hydroxybutyric Acid |2 NLM | |
650 | 7 | |a TZP1275679 |2 NLM | |
700 | 1 | |a Kyriakidou, Yvoni |e verfasserin |4 aut | |
700 | 1 | |a Edwards, Kurtis |e verfasserin |4 aut | |
700 | 1 | |a Petagine, Lucy |e verfasserin |4 aut | |
700 | 1 | |a Seyfried, Thomas N |e verfasserin |4 aut | |
700 | 1 | |a Duraj, Tomas |e verfasserin |4 aut | |
700 | 1 | |a Soto-Mota, Adrian |e verfasserin |4 aut | |
700 | 1 | |a Scarborough, Andrew |e verfasserin |4 aut | |
700 | 1 | |a Jacome, Sandra L |e verfasserin |4 aut | |
700 | 1 | |a Brookler, Kenneth |e verfasserin |4 aut | |
700 | 1 | |a Borgognoni, Valentina |e verfasserin |4 aut | |
700 | 1 | |a Novaes, Vanusa |e verfasserin |4 aut | |
700 | 1 | |a Al-Faour, Rima |e verfasserin |4 aut | |
700 | 1 | |a Elliott, Bradley T |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d 2008 |g 24(2023), 21 vom: 26. Okt. |w (DE-627)NLM185552161 |x 1422-0067 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2023 |g number:21 |g day:26 |g month:10 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijms242115621 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2023 |e 21 |b 26 |c 10 |